Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Multi-functionalized heteroduplex antisense oligonucleotides for targeted intracellular delivery and gene silencing in hela cells
Concentration (start) Volume (start) = Concentration (final) Volume (final) Purity & Documentation Data Sheet (277 KB) SDS (252 KB) English - EN (252 KB) Franais - FR (252 KB) Deutsch - DE (252 KB) Norwegian - NO (252 KB) Espaol - ES (252 KB) Swedish - SV (252 KB) Italian - IT (252 KB) Korean - KR (252 KB) Portuguese - PT (252 KB) Handling Instructions (2659 KB) References Complete Stock Solution Preparation Table Please refer to the solubility information to select the appropriate solvent
Recent developments in Bells palsy
doi: 10.3389/fpsyg.2015.00678, 65 MuL.XiaD.CaiJ.GuB.LiuX.FriedmanV.et al
Phase Cag introduction Weeks 9-12 Tirzepatide 5.0 mg/week (hold) Cagrilintide 0.25 mg/week Notes Add cagrilintide at the lowest dose
)
US$ 28.55
US$ 23.47
)
US$ 27.38
)
US$ 27.93
US$ 21.57
